Table 1 Characteristics and medication details for the subset of patients included in the HLA class 1 SAB data set^a

Number of kidney transplant recipients

34

18

–

Age at time of transplantation (years)

57.9 ± 11.0

51.6 ± 11.6

0.04

Body mass index at time of transplantation (kg/m²)

27.7 ± 5.4

24.2 ± 4.2

0.01

 Female

17 (50.0%)

7 (38.9%)

ns^b

 Male

17 (50.0%)

11 (61.1%)

 Living

7 (20.6%)

4 (22.2%)

ns^c

 Deceased

27 (79.4%)

14 (77.8%)

Re-transplantation

3 (8.8%)

0 (0.0%)

ns^c

 0

11 (32.4%)

9 (50.0%)

ns^c

 1

18 (52.9%)

8 (44.4%)

 2

5 (14.7%)

1 (5.6%)

 0

3 (8.8%)

4 (22.2%)

ns^c

 1

18 (52.9%)

11 (61.1%)

 2

13 (38.2%)

3 (16.7%)

 0

3 (8.8%)

7 (38.9%)

0.03^c

 1

20 (58.8%)

9 (50.0%)

 2

11 (32.4%)

2 (11.1%)

PRA = 0%

31 (91.2%)

16 (88.9%)

ns^c

 A

12 (35.3%)

6 (33.3%)

ns^c

 B

10 (29.4%)

3 (16.7%)

 C

12 (35.3%)

9 (50.0%)

Cold ischemia time: only deceased donors (min)

739 ± 295

637 ± 302

ns